<VariationArchive VariationID="282860" VariationName="NM_000232.5(SGCB):c.1_2del (p.Met1fs)" VariationType="Deletion" Accession="VCV000282860" Version="21" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-03-17" DateCreated="2017-08-20" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="267097" VariationID="282860">
      <GeneList>
        <Gene Symbol="LOC129992585" FullName="ATAC-STARR-seq lymphoblastoid silent region 15421" GeneID="129992585" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="52038072" stop="52038511" display_start="52038072" display_stop="52038511" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SGCB" FullName="sarcoglycan beta" GeneID="6443" HGNC_ID="HGNC:10806" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>4q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="52020706" stop="52038299" display_start="52020706" display_stop="52038299" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="52886860" stop="52904484" display_start="52886860" display_stop="52904484" Strand="-" />
          </Location>
          <OMIM>600900</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000232.5(SGCB):c.1_2del (p.Met1fs)</Name>
      <CanonicalSPDI>NC_000004.12:52038257:AT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>4q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="52038258" stop="52038259" display_start="52038258" display_stop="52038259" variantLength="2" positionVCF="52038257" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="52904424" stop="52904425" display_start="52904424" display_stop="52904425" variantLength="2" positionVCF="52904423" referenceAlleleVCF="CAT" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000232.4" sequenceAccession="NM_000232" sequenceVersion="4" change="c.1_2delAT">
            <Expression>NM_000232.4:c.1_2delAT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.11" sequenceAccession="NC_000004" sequenceVersion="11" change="g.52904424_52904425del" Assembly="GRCh37">
            <Expression>NC_000004.11:g.52904424_52904425del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000004.12" sequenceAccession="NC_000004" sequenceVersion="12" change="g.52038258_52038259del" Assembly="GRCh38">
            <Expression>NC_000004.12:g.52038258_52038259del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008891.1" sequenceAccession="NG_008891" sequenceVersion="1" change="g.5061_5062del">
            <Expression>NG_008891.1:g.5061_5062del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000232.5" sequenceAccession="NM_000232" sequenceVersion="5" change="c.1_2del" MANESelect="true">
            <Expression>NM_000232.5:c.1_2del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000223.1" sequenceAccession="NP_000223" sequenceVersion="1" change="p.Met1fs">
            <Expression>NP_000223.1:p.Met1fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
          <MolecularConsequence ID="SO:0001582" Type="initiator_codon_variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_204" sequenceAccession="LRG_204">
            <Expression>LRG_204:g.5061_5062del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10604324" DB="ClinGen" />
        <XRef Type="rs" ID="886042503" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00004" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00005" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00006" Source="Trans-Omics for Precision Medicine (TOPMed)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000232.5(SGCB):c.1_2del (p.Met1fs) AND not provided" Accession="RCV000498910" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2018-07-18" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000232.5(SGCB):c.1_2del (p.Met1fs) AND Qualitative or quantitative defects of beta-sarcoglycan" Accession="RCV000778734" Version="4">
        <ClassifiedConditionList TraitSetID="9572">
          <ClassifiedCondition DB="MedGen" ID="C2930900">Qualitative or quantitative defects of beta-sarcoglycan</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-07-10" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000232.5(SGCB):c.1_2del (p.Met1fs) AND Autosomal recessive limb-girdle muscular dystrophy type 2E" Accession="RCV000812020" Version="12">
        <ClassifiedConditionList TraitSetID="2394">
          <ClassifiedCondition DB="MedGen" ID="C1858593">Autosomal recessive limb-girdle muscular dystrophy type 2E</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-30" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-30" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2017-08-20" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12566530</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15938573</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18996010</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25862795</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SGCB</URL>
        </Citation>
        <DescriptionHistory Dated="2019-05-24">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9572" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="13388" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Qualitative or quantitative defects of beta-sarcoglycan</ElementValue>
                <XRef ID="MONDO:0016142" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-sarcoglycanopathy</ElementValue>
                <XRef ID="Beta-Sarcoglycanopathy/816" DB="Genetic Alliance" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20391" />
                <XRef ID="20391" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="870" />
                <XRef ID="870" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="207063" DB="Orphanet" />
              <XRef ID="C2930900" DB="MedGen" />
              <XRef ID="MONDO:0016142" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2394" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5571" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive limb-girdle muscular dystrophy type 2E</ElementValue>
                <XRef ID="MONDO:0011423" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 4</ElementValue>
                <XRef Type="MIM" ID="604286" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="600900.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Muscular dystrophy limb-girdle with beta-sarcoglycan deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Beta-sarcoglycan limb-girdle muscular dystrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Limb-girdle muscular dystrophy, type 2E</ElementValue>
                <XRef ID="Limb-girdle+muscular+dystrophy%2C+type+2E/4240" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LGMDR4</ElementValue>
                <XRef Type="MIM" ID="604286" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism">Affects gamma-sarcoglycan and also disrupts the integrity of the entire sarcoglycan complex.</Attribute>
                <XRef ID="GTR000509009" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3851" />
                <XRef ID="3851" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="119" DB="Orphanet" />
              <XRef ID="C1858593" DB="MedGen" />
              <XRef ID="MONDO:0011423" DB="MONDO" />
              <XRef Type="MIM" ID="604286" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="648083" SubmissionDate="2018-09-19" DateLastUpdated="2023-09-03" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="33894_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000334560" DateUpdated="2023-09-03" DateCreated="2016-12-06" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-07-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL ClinVar v180209 classification definitions</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/kvqgb2ud/egl_clinvar_v180209_classification_definitions.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="4" alternateAllele="-" referenceAllele="AT" start="52904424" stop="52904425" variantLength="2" />
            <GeneLocation>NM_000232.4:Ex1</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD086203" />
            <XRef DB="dbSNP" ID="886042503" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=SGCB</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1143295" SubmissionDate="2019-01-29" DateLastUpdated="2023-09-03" DateCreated="2017-08-20">
        <ClinVarSubmissionID localKey="GDX:745854|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000589651" DateUpdated="2023-09-03" DateCreated="2017-08-20" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-06-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.1_2delAT pathogenic variant in the SGCB gene has been reported previously in two unrelated individuals with sacroglycanopathy who also a second pathogenic variant in SGCB identified (Klinge et al., 2008). Immunohistochemistry of muscle biopies from both patients showed reduction of beta, gamma, and delta sarcoglycan (Klinge et al., 2008). The variant alters the initiator Methionine codon, and the resultant protein would be described as p.Met1?" using a question mark to signify that it is not known if the loss of Met1 means that all protein translation is completely prevented or if an abnormal protein is produced using an alternate Met."</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.4:c.1_2delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1790163" SubmissionDate="2019-02-01" DateLastUpdated="2023-09-03" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="1322225" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000915092" DateUpdated="2023-09-03" DateCreated="2019-05-27" Type="SCV" Version="2" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-07-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18996010</ID>
          </Citation>
          <Comment>The SGCB c.1_2delAT (p.Met1?) variant has been reported in a single study and was found in a compound heterozygous state with the same missense variant in two unrelated individuals with a severe phenotype of beta-sarcoglycanopathy (Klinge et al. 2008). Control data are unavailable for this variant, and it is not found in the 1000 Genomes Project, the Exome Sequencing Project, Exome Aggregation Consortium, or Genome Aggregation Database. However, the coverage of this genomic region may not have been adequate to provide an accurate estimate of the true population frequency. The p.Met1? variant interrupts the initiation codon, and although functional studies of the variant have not been conducted, both compound heterozygous patients showed absent or reduced beta-sarcoglycan expression on immunohistochemistry of muscle biopsies. Based on the evidence, the p.Met1? variant is classified as likely pathogenic for beta-sarcoglycanopathy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="4" alternateAllele="C" referenceAllele="CAT" start="52904423" stop="52904425" variantLength="3" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.4:c.1_2delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Beta-sarcoglycanopathy</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C2930900" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292024" SubmissionDate="2019-09-27" DateLastUpdated="2023-09-03" DateCreated="2020-02-28">
        <ClinVarSubmissionID localKey="NC_000004.11:g.52904424_52904425delAT|OMIM:604286" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001162968" DateUpdated="2023-09-03" DateCreated="2020-02-28" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.52904424_52904425delAT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604286" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2862772" SubmissionDate="2020-11-26" DateLastUpdated="2023-09-03" DateCreated="2020-12-10">
        <ClinVarSubmissionID localKey="NM_000232.5:c.1_2del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001449906" DateUpdated="2023-09-03" DateCreated="2020-12-10" Type="SCV" Version="2" SubmitterName="Clinical Genetics and Genomics, Karolinska University Hospital" OrgID="505315" OrganizationCategory="laboratory" OrgAbbreviation="KLINGEN-KUS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.5:c.1_2del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8639822</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4072022" SubmissionDate="2022-02-09" DateLastUpdated="2023-09-03" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_000232.5:c.1_2del|Limb-girdle muscular dystrophy type 2E" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002083004" DateUpdated="2023-09-03" DateCreated="2022-04-23" Type="SCV" Version="2" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.5:c.1_2del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Limb-girdle muscular dystrophy type 2E</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7131604" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="146a5931989a8e4f7ffc0d62447170b018634cc7e927b343b3d59204b260112c|OMIM:604286" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003825623" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000232.4:c.1_2del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="604286" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1846451" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="2435826|MedGen:C1858593" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000952318" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="7" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12566530</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15938573</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18996010</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25862795</ID>
          </Citation>
          <Comment>This sequence change affects the initiator methionine of the SGCB mRNA. The next in-frame methionine is located at codon 22. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. Disruption of the initiator codon has been observed in individuals with clinical features of SGCB-related conditions (PMID: 12566530, 15938573, 18996010, 25862795). ClinVar contains an entry for this variant (Variation ID: 282860). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SGCB" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000004.11:g.52904424_52904425del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858593" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1846451" TraitType="Disease" MappingType="XRef" MappingValue="C1858593" MappingRef="MedGen">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1790163" TraitType="Disease" MappingType="Name" MappingValue="Beta-sarcoglycanopathy" MappingRef="Preferred">
        <MedGen CUI="C2930900" Name="Qualitative or quantitative defects of beta-sarcoglycan" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292024" TraitType="Disease" MappingType="XRef" MappingValue="604286" MappingRef="OMIM">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7131604" TraitType="Disease" MappingType="XRef" MappingValue="604286" MappingRef="OMIM">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="648083" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2862772" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1143295" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4072022" TraitType="Disease" MappingType="Name" MappingValue="Limb-girdle muscular dystrophy type 2E" MappingRef="Preferred">
        <MedGen CUI="C1858593" Name="Autosomal recessive limb-girdle muscular dystrophy type 2E" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

